NIT
ONCE

NumerixS Investment Technologies’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

NumerixS Investment Technologies’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,800
Closed -$208K – 1524
2018
Q3 		$208K Buy
3,800
+3,600
+1,800% +$246K 0.04% 572
2018
Q2 		$17K Buy
+200
New +$15.4K ﹤0.01% 1029
2017
Q4 		– Sell
-200
Closed -$18K – 1450
2017
Q3 		$18K Sell
200
-3,300
-94% -$251K ﹤0.01% 1064
2017
Q2 		$209K Buy
3,500
+1,500
+75% +$83.8K 0.03% 627
2017
Q1 		$107K Sell
2,000
-1,200
-38% -$71.2K 0.01% 872
2016
Q4 		$160K Buy
+3,200
New +$171K 0.02% 748
2015
Q3 		– Sell
-5,800
Closed -$350K – 838
2015
Q2 		$350K Buy
+5,800
New +$383K 0.05% 459

Other funds holding ONCE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return